AsiaEnvironment Intensifying heat waves prompt health warnings for Europe, US The Cheap InvestorJuly 18, 2023July 18, 20230 By Liliana Salgado PHOENIX (Reuters) -A global pattern of heat waves scorching parts of Europe, Asia and the United States…
BusinessHealth J&J sues in latest bid to halt Medicare drug price negotiations The Cheap InvestorJuly 18, 2023July 18, 20230 (Reuters) -Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that…
BusinessHealth Teladoc expands Microsoft tie-up to document patient visits with AI The Cheap InvestorJuly 18, 2023July 18, 20230 (Reuters) – Teladoc Health is expanding a partnership with Microsoft to use the tech giant’s artificial intelligence services to automate…
BusinessHealth Pfizer, Flagship Pioneering to invest $100 million in drug discovery The Cheap InvestorJuly 18, 2023July 18, 20230 (Reuters) -U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop…
AsiaHealth Childhood vaccination rates begin to recover post-pandemic – but not everywhere, U.N. says The Cheap InvestorJuly 18, 2023July 18, 20230 By Jennifer Rigby LONDON (Reuters) – Efforts to vaccinate children worldwide against deadly diseases such as measles and diphtheria began…
EnvironmentEurope Explainer-The health risks of extreme heat The Cheap InvestorJuly 18, 2023July 18, 20230 By Jennifer Rigby and Kate Turton LONDON (Reuters) – The world is baking under extreme heat – with Asia, Europe…
HealthTop News Experimental drug works best for Alzheimer’s patients treated as early as possible The Cheap InvestorJuly 17, 2023July 17, 20230 By Deena Beasley (Reuters) -An experimental drug from Eli Lilly works best if Alzheimer’s patients are treated as early as…
BusinessHealth AT&T shares hit three-decade low as lead cables risk weighs The Cheap InvestorJuly 17, 2023July 17, 20230 By Chibuike Oguh NEW YORK (Reuters) -Shares of AT&T Inc fell nearly 7% to hit their lowest level in thirty…
HealthTop News US FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies The Cheap InvestorJuly 17, 2023July 17, 20230 (Reuters) -The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy…
BusinessHealth Acumen’s Alzheimer’s drug passes initial safety test The Cheap InvestorJuly 17, 2023July 17, 20230 By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals targeting a novel form of…